Company intelligence / Profile preview

AirLabs

London, Greater London, United Kingdomairlabs.co ↗

Ownership: Private
Employees: ~25
Development stage: Other

Overview

AirLabs develops scientifically validated devices for real-time air quality monitoring and personal/indoor air purification. Their flagship product, AirBubbl, has been proven to remove particulates—including viruses—and gaseous pollutants from indoor environments. They provide actionable data to governments, businesses, and individuals to improve urban environmental health.

Therapeutic areas: PulmonologyInfectious Diseases
Modalities: DeviceSensor technology
Industry: Therapeutic Medical Devices

Partnerships

Collaborations with cities/governments for urban deploymentPartnership with GoAscendal mobility accelerator for UK market expansion

Beyond the preview

Go deeper on AirLabs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AirLabs.

Explore the full profile